Two biotech companies, APEIRON and Evotec, have received the first milestone payment from Sanofi as part of the three-party immune-oncology alliance that was signed in 2015. Read more


Driven by increasing demand for its chromatography purification capabilities from the drug discovery, contract research and agrochemical sectors, Reach Separations is set to double laboratory space at its UK-based facility. Read more


Evotec has entered into exclusive negotiations with Sanofi on a major multi-component strategic alliance over the next five years. Read more


A strategic alliance with Evotec will see UK-based Reach Separations provide additional purification and analytical capability to support Evotec’s pharmaceutical and biotech clients worldwide. As part of the deal, the purification specialist will... Read more